Role of NT-proBNP for Atrial Fibrillation Detection After Ischemic Stroke: A Time-Dependent Relationship

Atrial FibrillationThrombosis and Stroke

Risk of ischemic stroke in sinus node dysfunction with and without atrial fibrillation: evidence for the presence of a left atrial myopathy in patients with isolated sinus node dysfunction - an analysis of the UK Biobank

Heart Rhythm

Virk SA, Ho WWH, Takeuchi F, Morris GM, Kistler PM, Kalman J

doi: 10.1016/j.hrthm.2025.04.055

Atrial FibrillationThrombosis and Stroke

Sex Differences and 2-Year Mortality in Patients With Atrial Fibrillation Diagnosed After Stroke and Known Atrial Fibrillation: A Register-Based Study in Sweden

J Am Heart Assoc

Al Khatib I, Viktorisson A, Abzhandadze T, Sunnerhagen KS

doi: 10.1161/JAHA.124.037608

Atrial Fibrillation

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Heart Rhythm

Boriani G, McIntyre WF, Ramasundarahettige C, Proietti M, Glotzer TV, Diemberger I, Nielsen JC, Essebag V, Granger CB, Sandhu RK, Benezet-Mazuecos J, Mabo P, Coutu B, Wong JA, Gold MR, Lopes RD, Healey JS, ARTESiA Investigators

doi: 10.1016/j.hrthm.2025.07.002

Atrial FibrillationThrombosis and Stroke

Association of Rate-Control and Antiarrhythmic Medication Use and Risk of Ischemic Stroke and Death in Patients on Dialysis With Atrial Fibrillation

J Am Heart Assoc

Lidgard B, Fan DX, Zelnick LR, An J, Harrison TN, Lee MS, Singer D, Tabada GH, Go AS, Bansal N

doi: 10.1161/JAHA.124.038511

Atrial FibrillationThrombosis and Stroke

Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)

Lancet

Dehbi HM, Fischer U, Åsberg S, Milling TJ, Abend S, Ahmed N, Branca M, Davis LA, Engelter ST, Freemantle N, Gattringer T, Ghukasyan Lakic T, Hijazi Z, James M, Koga M, Lawrence P, Lemmens R, Lip GYH, Massingham S, Nash PS, Ndoutoumou A, Norrving B, Salanti G, Sprigg N, Thomalla G, Vanniyasingam T, Wester P, Warach SJ, Oldgren J, Dawson J, Werring DJ

doi: 10.1016/S0140-6736(25)00439-8

Atrial FibrillationThrombosis and StrokeTherapy and Intervention

Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: a subgroup analysis of ARTESiA

Heart Rhythm

Xing LY, Lopes RD, McIntyre WF, Sandhu RK, Rubio Campal JM, Khoo C, Granger CB, Gold MR, Svendsen JH, Diederichsen SZ, Alings M, Mabo P, Kutyifa V, Nielsen JC, Birnie DH, Benz AP, Mani T, Ramasundarahettige C, Healey JS

doi: 10.1016/j.hrthm.2025.07.048

Atrial FibrillationThrombosis and Stroke

Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation

J Am Coll Cardiol

Wallentin L, Lindbäck J, Hijazi Z, Oldgren J, Carnicelli AP, Alexander JH, Berg DD, Eikelboom JW, Goto S, Lopes RD, Ruff CT, Siegbahn A, Giugliano RP, Granger CB, Morrow DA

doi: 10.1016/j.jacc.2024.11.052

Atrial FibrillationThrombosis and Stroke

Left Atrial Appendage Closure versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Long-Term Outcomes from Four Randomized Trials

Heart Rhythm

Kaisaier W, Xu Z, Guo L, Dong Y, Chen Y, Lip GYH, Zhu W

doi: 10.1016/j.hrthm.2025.07.051

Thrombosis and Stroke

Relationship Between Neutrophil Count and 90-Day Outcomes and Effect of Dual Antiplatelet Therapy in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the INSPIRES Trial

J Am Heart Assoc

Wang Y, Pan Y, Wang X, Gao Y, Chen W, Johnston SC, Bath PM, Amarenco P, Gao C, Wang Y, Liao X, Wang Y

doi: 10.1161/JAHA.124.040492

Related content

Risk of ischemic stroke in sinus node dysfunction with and without atrial fibrillation: evidence for the presence of a left atrial myopathy in patients with isolated sinus node dysfunction - an analysis of the UK Biobank

Sex Differences and 2-Year Mortality in Patients With Atrial Fibrillation Diagnosed After Stroke and Known Atrial Fibrillation: A Register-Based Study in Sweden

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Association of Rate-Control and Antiarrhythmic Medication Use and Risk of Ischemic Stroke and Death in Patients on Dialysis With Atrial Fibrillation

Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)

Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: a subgroup analysis of ARTESiA

Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation

Left Atrial Appendage Closure versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Long-Term Outcomes from Four Randomized Trials

Relationship Between Neutrophil Count and 90-Day Outcomes and Effect of Dual Antiplatelet Therapy in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the INSPIRES Trial